Literature DB >> 34875213

Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex.

Shafqat Rasool1, Simon Veyron1, Naoto Soya2, Mohamed A Eldeeb3, Gergely L Lukacs2, Edward A Fon3, Jean-François Trempe4.   

Abstract

Mutations in PINK1 cause autosomal-recessive Parkinson's disease. Mitochondrial damage results in PINK1 import arrest on the translocase of the outer mitochondrial membrane (TOM) complex, resulting in the activation of its ubiquitin kinase activity by autophosphorylation and initiation of Parkin-dependent mitochondrial clearance. Herein, we report crystal structures of the entire cytosolic domain of insect PINK1. Our structures reveal a dimeric autophosphorylation complex targeting phosphorylation at the invariant Ser205 (human Ser228). The dimer interface requires insert 2, which is unique to PINK1. The structures also reveal how an N-terminal helix binds to the C-terminal extension and provide insights into stabilization of PINK1 on the core TOM complex.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PINK1; Parkin; Parkinson; TOM; X-ray crystallography; kinase; mass spectrometry; mitochondria; phosphorylation; ubiquitin

Mesh:

Substances:

Year:  2021        PMID: 34875213     DOI: 10.1016/j.molcel.2021.11.012

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  10 in total

1.  Mitochondria in neurodegeneration.

Authors:  Charleen T Chu
Journal:  Curr Opin Physiol       Date:  2022-04-01

Review 2.  PINK1/Parkin Pathway Activation for Mitochondrial Quality Control - Which Is the Best Molecular Target for Therapy?

Authors:  Laura F Silvian
Journal:  Front Aging Neurosci       Date:  2022-06-08       Impact factor: 5.702

Review 3.  Mechanisms underlying ubiquitin-driven selective mitochondrial and bacterial autophagy.

Authors:  Ellen A Goodall; Felix Kraus; J Wade Harper
Journal:  Mol Cell       Date:  2022-03-31       Impact factor: 19.328

4.  The role of the individual TOM subunits in the association of PINK1 with depolarized mitochondria.

Authors:  Klaudia K Maruszczak; Martin Jung; Shafqat Rasool; Jean-François Trempe; Doron Rapaport
Journal:  J Mol Med (Berl)       Date:  2022-04-07       Impact factor: 5.606

Review 5.  Therapeutic targeting of mitophagy in Parkinson's disease.

Authors:  Shashank Masaldan; Sylvie Callegari; Grant Dewson
Journal:  Biochem Soc Trans       Date:  2022-04-29       Impact factor: 4.919

6.  A secretory form of Parkin-independent mitophagy contributes to the repertoire of extracellular vesicles released into the tumour interstitial fluid in vivo.

Authors:  Marissa Howard; James Erickson; Zachary Cuba; Shawn Kim; Weidong Zhou; Purva Gade; Rachel Carter; Kelsey Mitchell; Heather Branscome; Daivik Siddhi; Fatimah Alanazi; Yuriy Kim; Robyn P Araujo; Amanda Haymond; Alessandra Luchini; Fatah Kashanchi; Lance A Liotta
Journal:  J Extracell Vesicles       Date:  2022-07

7.  Systematic Functional Analysis of PINK1 and PRKN Coding Variants.

Authors:  Benjamin J Broadway; Paige K Boneski; Jenny M Bredenberg; Ana Kolicheski; Xu Hou; Alexandra I Soto-Beasley; Owen A Ross; Wolfdieter Springer; Fabienne C Fiesel
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

Review 8.  Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy.

Authors:  Xiao-Yan Gao; Tuo Yang; Ying Gu; Xiao-Hong Sun
Journal:  Front Aging Neurosci       Date:  2022-06-20       Impact factor: 5.702

9.  Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma.

Authors:  Hao Chen; Jianlin Zhang; Xuehu Sun; Yao Wang; Yeben Qian
Journal:  Front Cell Dev Biol       Date:  2022-07-22

10.  Selective localization of Mfn2 near PINK1 enables its preferential ubiquitination by Parkin on mitochondria.

Authors:  Marta Vranas; Yang Lu; Shafqat Rasool; Nathalie Croteau; Jonathan D Krett; Véronique Sauvé; Kalle Gehring; Edward A Fon; Thomas M Durcan; Jean-François Trempe
Journal:  Open Biol       Date:  2022-01-19       Impact factor: 6.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.